Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hetero Labs Limited Unit V
WARNING LETTER
•Hetero Labs Limited Unit V•December 16, 2016

Hetero Labs Limited Unit V – FDA Warning Letter, Dec 16, 2016

Record Details

The FDA issued a Warning Letter to Hetero Labs Limited, Unit V, following an inspection from December 7-16, 2016, identifying significant CGMP violations for finished pharmaceuticals, rendering their drug products adulterated under 21 U.S.C. 351(a)(2)(B).

Key violations include: 1. **Insufficient Investigations (21 CFR 211.192):** The firm failed to thoroughly investigate unexplained discrepancies or OOS results. For example, a customer complaint regarding dissolution failure for (b)(4) mg (b)(4) tablets (lot (b)(4)) was inadequately investigated, with inconsistent conclusions and a failure to identify the root cause or scope of the issue. The FDA requires updated dissolution testing, a retrospective review of all investigations and manufacturing process validations for U.S.-bound products, and a plan for future thorough investigations. 2. **Equipment Cleaning and Maintenance (21 CFR 211.67(a)):** Investigators observed "clean" equipment with colored residue and in poor condition, such as (b)(4) PDE-2095 having white residue and a damaged gasket. The firm's explanation was deemed insufficient. The FDA demands sampling procedures and analytical methods for residues, procedures for gasket installation/maintenance, an assessment of similar gaskets, and an overall assessment of the cleaning program, including cleaning validation studies. 3.

Company
Hetero Labs Limited Unit V
Inspection date
December 16, 2016
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas J. Cosgrove
View Company Profile

ID · 137ac1a2-0424-451c-a0ef-c758b2e332b9

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.67(a)21 CFR 211.22(d)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)21 U.S.C. 356C(b)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hetero Labs Limited Unit V
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.